Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00903448 · ClinicalTrials.gov registry record · Phase 4
Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression
A Phase 4 study, sponsored by Procter and Gamble.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00903448: Completed Phase 4 study, sponsored by Procter and Gamble.
NCT00903448 is a Phase 4 study that has completed, run by Procter and Gamble. The registered enrollment target is 40 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00903448, a Phase 4 study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The objective of this study is to compare Prilosec OTC® to Prevacid® for gastric acid suppression.
Primary Outcome
for 24 hours starting Day 5 for each period
Interventions
- DRUG Prevacid
- DRUG Prilosec OTC (omeprazole-magnesium)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
What the finished NCT00903448 record still lists
NCT00903448 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Prevacid is the first listed.
NCT00903448 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00903448 about?
NCT00903448 is a clinical study titled "Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression". The objective of this study is to compare Prilosec OTC® to Prevacid® for gastric acid suppression.
What is the current status of trial NCT00903448?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2009-04. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00903448?
The interventions under investigation include: Prevacid (DRUG), Prilosec OTC (omeprazole-magnesium) (DRUG).
Who is sponsoring clinical trial NCT00903448?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00903448's enrollment target sits among peer trials
40 1397th of 2000 higher than 533 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia